Cargando…
Abrupt hemodynamic changes accompanying intrapleural hyperthermic chemotherapy: Case series
RATIONALE: Intrapleural hyperthermic chemotherapy (IPHC) is the preferred method to locally treat lung cancer with pleural seeding. Anesthetic management during IPHC is a very challenging task for the anesthesiologist because of the hemodynamic instability associated with the procedure; however, the...
Autores principales: | Kim, Hyae-Jin, Lee, Hyeon-Jeong, Kim, Eunsoo, Yun, Jihwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023850/ https://www.ncbi.nlm.nih.gov/pubmed/29923981 http://dx.doi.org/10.1097/MD.0000000000010982 |
Ejemplares similares
-
Hyperthermic intrapleural chemotherapy: an update
por: Campany, Megan E., et al.
Publicado: (2023) -
Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
por: Yu, Lei, et al.
Publicado: (2013) -
Physiologic and hemodynamic changes in patients undergoing open abdominal cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Kim, Myoung Hwa, et al.
Publicado: (2021) -
EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment
por: Zhang, Hongjuan, et al.
Publicado: (2015) -
Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment
por: Zhang, Hongjuan, et al.
Publicado: (2018)